John Zamparo Analyst Performance

Analyst at Scotiabank

John Zamparo is a stock analyst at Scotiabank focused in the medical sector, covering 14 publicly traded companies. Over the past year, John Zamparo has issued 6 stock ratings, including strong buy, buy, and hold recommendations. While full access to John Zamparo's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights John Zamparo's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 35 Last 6 Years
Buy Recommendations: 37.50% 12 Buy Ratings
Companies Covered: 14 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	3.1%	1 ratings
Buy	34.4%	11 ratings
Hold	43.8%	14 ratings
Sell	18.8%	6 ratings

Out of 32 total stock ratings issued by John Zamparo at Scotiabank, the majority (43.8%) have been Hold recommendations, followed by 34.4% Buy, 18.8% Sell, and 3.1% Strong Buy.

Best & Worst Calls

Best Call
000.0%
MTY
Feb 2022
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
HEXO
Sep 2021
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
TSE	35.7% of companies on TSE	5 companies
NASDAQ	35.7% of companies on NASDAQ	5 companies
NYSE	21.4% of companies on NYSE	3 companies
OTCMKTS	7.1% of companies on OTCMKTS	1 company

John Zamparo, an analyst at Scotiabank, currently covers 14 companies listed on TSE, NASDAQ, NYSE and OTCMKTS, with the majority traded on TSE.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 11 companies	78.6%
	Consumer Discretionary 1 company	7.1%
	Retail/Wholesale 1 company	7.1%
	Consumer Cyclical 1 company	7.1%

John Zamparo of Scotiabank specializes in stock coverage within the Medical sector, with additional focus on Consumer Discretionary and Retail/Wholesale companies.

Coverage Industries

Industry	Percentage
DRUG MANUFACTURERS - SPECIALTY & GENERIC 6 companies	42.9%
MED PRODUCTS 3 companies	21.4%
TEXTILE - APPAREL 1 company	7.1%
RETAIL - RESTRNTS 1 company	7.1%
RESTAURANTS 1 company	7.1%
MEDICINALS & BOTANICALS 1 company	7.1%
MED - DRUGS 1 company	7.1%

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
GIL Gildan Activewear	8/14/2025	Reiterated Rating	$56.47		Outperform
GIL Gildan Activewear	8/14/2025	Boost Price Target	$57.10	$62.00	Outperform
QSR Restaurant Brands International	8/8/2025	Lower Price Target	$64.82	$71.00	Sector Perform
GIL Gildan Activewear	8/1/2025	Boost Price Target	$50.97	$59.00	Sector Outperform
GIL Gildan Activewear	5/28/2025	Upgrade	$49.55	$55.00	Strong-Buy
QSR Restaurant Brands International	5/9/2025	Lower Price Target	$67.19	$77.00

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.